P2-317: Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group
Saved in:
Published in | Journal of thoracic oncology Vol. 2; no. 8; p. S699 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.08.2007
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!